Showing results (401-410 of 518) with videos related to
Sort By:
Pageof 52
Molecular Imaging and Radionuclide Therapy|February 23, 2023
Findings of I-131 SPECT/CT, 18F-FDG, and 68Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid CarcinomaGamze Tatar, Göksel Alçın, Özge Erol Fenercioğlu, et al.Molecular Imaging and Radionuclide Therapy|February 23, 2023
11C-Methionine PET/CT and 18F-FDG PET/CT in the Evaluation of Adult Alveolar RhabdomyosarcomaYuka Hiroshima, Yoichi Otomi, Takayoshi Shinya, et al.Molecular Imaging and Radionuclide Therapy|February 23, 2023
A Rare Case and Atypical Metastatic Regions, Pulmonary Giant Cell CarcinomaCeyda Nur Dündar Çağlayan, Müge Nur Engin, Adil BozMolecular Imaging and Radionuclide Therapy|March 15, 2017
The Correlation Between Pre-treatment Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Parameters and Clinical Prognostic Factors in Pediatric Hodgkin LymphomaEbru Tatcı, İnci Uslu Biner, Suna Emir, et al.Molecular Imaging and Radionuclide Therapy|March 15, 2017
Assessment of the Prevalence of Diabetic Gastroparesis and Validation of Gastric Emptying Scintigraphy for DiagnosisZeinab Alipour, Foad Khatib, Seyed Masoud Tabib, et al.Molecular Imaging and Radionuclide Therapy|March 22, 2014
Scintigraphic methods to evaluate alterations of gastric and esophageal functions in female obesityOzgür Omür, Mehmet Erdoğan, Hayal Ozkılıç, et al.Molecular Imaging and Radionuclide Therapy|March 22, 2014
Findings of bone scintigraphy after leech theraphySinem Ozyurt, Gökhan Koca, Koray Demirel, et al.Molecular Imaging and Radionuclide Therapy|March 22, 2014
Multifoci Bone Tuberculosis and Lymphadenitis in Mediastinum Mimics Malignancy on FDG-PET/CT: A Case ReportNalan Alan Selçuk, Ayşen Fenercioğlu, Hatem Hakan Selçuk, et al.Molecular Imaging and Radionuclide Therapy|January 25, 2017
Nuclear Molecular and Theranostic Imaging for Differentiated Thyroid CancerArif Sheikh, Berna Polack, Yvette Rodriguez, et al.Molecular Imaging and Radionuclide Therapy|January 25, 2017
Redifferentiating Thyroid Cancer: Selumetinib-enhanced Radioiodine Uptake in Thyroid CancerSteven M Larson, Joseph R Osborne, Ravinder K Grewal, et al.Pageof 52